PAN-301-1
PAN0216
Phase 1 mab completed
Quick answer
PAN-301-1 for Prostate Cancer is a Phase 1 program (mab) at Sensei Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sensei Biotherapeutics
- Indication
- Prostate Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- completed